A Combination of δ-Tocotrienol and Ferulic Acid Synergistically Inhibits Telomerase Activity in DLD-1 Human Colorectal Adenocarcinoma Cells

被引:22
作者
Eitsuka, Takahiro [1 ]
Tatewaki, Naoto [1 ]
Nishida, Hiroshi [1 ]
Nakagawa, Kiyotaka [2 ]
Miyazawa, Teruo [2 ,3 ]
机构
[1] Niigata Univ Pharm & Appl Life Sci, Fac Appl Life Sci, Niigata 9568603, Japan
[2] Tohoku Univ, Grad Sch Agr Sci, Food & Biodynam Chem Lab, Sendai, Miyagi 9818555, Japan
[3] Tohoku Univ, Food Biotechnol Innovat Project NICHe, Sendai, Miyagi 9808579, Japan
关键词
tocotrienol; ferulic acid; synergy; telomerase; hTERT; COMBINED GAMMA-TOCOTRIENOL; QUANTITATION; SUPPRESSION; ACTIVATION; EXPRESSION; TOCOPHEROL;
D O I
10.3177/jnsv.62.281
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Rice bran is a rich source of functional compounds, including tocotrienol (T3) and ferulic acid (FA). We previously investigated the anti-cancer properties of T3, and reported on the potent inhibitory effects of delta-T3 on angiogenesis and telomerase activity. In this study, we examined the synergistic suppressive effects of the combination of delta-T3 and FA on telomerase activity in DLD-1 human colorectal adenocarcinoma cells. Co-treatment with delta-T3 and FA significantly decreased cellular telomerase activity compared to treatment with delta-T3 alone, whereas FA alone had no inhibitory effect. Co-treatment with delta-T3 and FA also synergistically down-regulated the expression of human telomerase reverse transcriptase (hTERT), the catalytic subunit of telomerase, indicating that the enzymatic activity of telomerase is controlled at the transcriptional level. FA significantly increased the intracellular concentration of delta-T3, suggesting that FA improved the bioavailability of delta-T3, thereby increasing the inhibitory potency of delta-T3 on telomerase. FA may be a promising candidate for augmenting the anti-cancer activity of delta-T3.
引用
收藏
页码:281 / 287
页数:7
相关论文
共 36 条
[1]   Mechanisms Mediating the Synergistic Anticancer Effects of Combined γ-Tocotrienol and Sesamin Treatment [J].
Akl, Mohamed R. ;
Ayoub, Nehad M. ;
Sylvester, Paul W. .
PLANTA MEDICA, 2012, 78 (16) :1731-1739
[2]  
Alexanian A, 2012, CANCER GENOM PROTEOM, V9, P163
[3]  
Bachawal SV, 2010, ANTICANCER RES, V30, P429
[4]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[5]   Polyunsaturated fatty acids inhibit telomerase activity in DLD-1 human colorectal adenocarcinoma cells: A dual mechanism approach [J].
Eitsuka, T ;
Nakagawa, K ;
Suzuki, T ;
Miyazawa, T .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2005, 1737 (01) :1-10
[6]   Telomerase inhibition by sulfoquinovosyldiacylglycerol from edible purple laver (Porphyra yezoensis) [J].
Eitsuka, T ;
Nakagawa, K ;
Igarashi, M ;
Miyazawa, T .
CANCER LETTERS, 2004, 212 (01) :15-20
[7]   Down-regulation of telomerase activity in DLD-1 human colorectal adenocarcinoma cells by tocotrienol [J].
Eitsuka, Takahiro ;
Nakagawa, Kiyotaka ;
Miyazawa, Teruo .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 348 (01) :170-175
[8]   Synergistic inhibition of cancer cell proliferation with a combination of δ-tocotrienol and ferulic acid [J].
Eitsuka, Takahiro ;
Tatewaki, Naoto ;
Nishida, Hiroshi ;
Kurata, Tadao ;
Nakagawa, Kiyotaka ;
Miyazawa, Teruo .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 453 (03) :606-611
[9]   The Myc/Max/Mad network and the transcriptional control of cell behavior [J].
Grandori, C ;
Cowley, SM ;
James, LP ;
Eisenman, RN .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2000, 16 :653-699
[10]   Targeting human telomerase for cancer therapeutics [J].
Guittat, L ;
Alberti, P ;
Gomez, D ;
De Cian, A ;
Pennarun, G ;
Lemarteleur, T ;
Belmokhtar, C ;
Paterski, R ;
Morjani, H ;
Trentesaux, C ;
Mandine, E ;
Boussin, F ;
Mailliet, P ;
Lacroix, L ;
Riou, JF ;
Mergny, JL .
CYTOTECHNOLOGY, 2004, 45 (1-2) :75-90